Catalyst-Rich 6 Months Ahead for Neurocrine Bio. (NBIX), Cowen Notes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Neurocrine Biosciences Reports Second Quarter 2015 Results
July 29, 2015 4:01 PM EDTSAN DIEGO, July 29, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2015. For the second quarter of 2015, the Company reported a net loss of $24.0 million, or $0.28 loss per share, compared to a net loss of $13.4 million, or $0.18 loss per share, for the same period in 2014. For the six months ended June 30, 2015, the Company reported a net loss of $25.2 million, or $0.30 loss per share, as compared to net loss of $25.2 million, or $0.35 loss per share, for the first half of last year.
The Company's... More
